---
figid: PMC5844108__40170_2018_174_Fig10_HTML
figlink: /pmc/articles/PMC5844108/figure/Fig10/
number: Fig. 10
caption: 'Schematic representation of different metabolic responses in acquiring FK866
  resistance in CEM RES (a) and MDA RES (b) cells. CEM RES cells are NAPRT-negative
  and QPRT-positive cells and appear to increase the de novo pathway for NAD production.
  The metabolic resistance of CEM is more dependent on glycolysis and LDHA activity
  whereas MDA RES shows very low level of QPRT and primarily rely on LDHA activity
  for its resistance to FK866. The small molecules having a pro-death pharmacological
  effect are indicated in green. Abbreviations: NAD, nicotinamide adenine dinucleotide;
  NA, nicotic acid; NAMN, nicotinic acid mononucleotide; NAAD, nicotinic acid adenine
  dinucleotide, NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT, nicotinamide
  mononucleotide adenylyltransferase; NADS, NAD synthase; NAM, nicotinamide; NMN,
  nicotinamide mononucleotide; NAMPT, nicotinamide phosphoribosyltransferase; NR,
  nicotinamide riboside; NRK, nicotinamide riboside kinase; QPRT, quinolinate phosphoribosyltransferase;
  HK, hexokinase; PFK, phosphofructokinase; PK, pyruvate kinase; LDH, lactate dehydrogenase;
  Gln, glutamine; Glu, glutamic acid; GSK, LDHA inhibitor; 2DG, 2-deoxyglucose; JPH,
  JPH203; L-Asp, l-asparaginase; GSK, GSK2837808A; LAT1, L-type amino acid transporter
  1'
pmcid: PMC5844108
papertitle: Cancer cell metabolic plasticity allows resistance to NAMPT inhibition
  but invariably induces dependence on LDHA.
reftext: Natthakan Thongon, et al. Cancer Metab. 2018;6:1.
pmc_ranked_result_index: '53545'
pathway_score: 0.9617893
filename: 40170_2018_174_Fig10_HTML.jpg
figtitle: Different metabolic responses in acquiring FK866 resistance in CEM RES (a)
  and MDA RES (b) cells
year: '2018'
organisms: Homo sapiens
ndex: 0bf2cb83-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5844108__40170_2018_174_Fig10_HTML.html
  '@type': Dataset
  description: 'Schematic representation of different metabolic responses in acquiring
    FK866 resistance in CEM RES (a) and MDA RES (b) cells. CEM RES cells are NAPRT-negative
    and QPRT-positive cells and appear to increase the de novo pathway for NAD production.
    The metabolic resistance of CEM is more dependent on glycolysis and LDHA activity
    whereas MDA RES shows very low level of QPRT and primarily rely on LDHA activity
    for its resistance to FK866. The small molecules having a pro-death pharmacological
    effect are indicated in green. Abbreviations: NAD, nicotinamide adenine dinucleotide;
    NA, nicotic acid; NAMN, nicotinic acid mononucleotide; NAAD, nicotinic acid adenine
    dinucleotide, NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT, nicotinamide
    mononucleotide adenylyltransferase; NADS, NAD synthase; NAM, nicotinamide; NMN,
    nicotinamide mononucleotide; NAMPT, nicotinamide phosphoribosyltransferase; NR,
    nicotinamide riboside; NRK, nicotinamide riboside kinase; QPRT, quinolinate phosphoribosyltransferase;
    HK, hexokinase; PFK, phosphofructokinase; PK, pyruvate kinase; LDH, lactate dehydrogenase;
    Gln, glutamine; Glu, glutamic acid; GSK, LDHA inhibitor; 2DG, 2-deoxyglucose;
    JPH, JPH203; L-Asp, l-asparaginase; GSK, GSK2837808A; LAT1, L-type amino acid
    transporter 1'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NAMPT
  - NAPRT
  - EIF2AK3
  - LDHA
  - TYRP1
  - PKIB
  - A4GALT
  - PKIA
  - QPRT
  - PKIG
  - RES
  - MDA RES
  - Trp
  - L-Asp
  - Gin Glu
  - NAMN
  - Glu
  - Glucose
  - NAD
  - NADS
  - NADH
  - Pyruvate
  - Lactate
  - NAMPT
  - TCA
  - Citrate
  - Succinate
  - ADP
  - ATP
genes:
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: PEK
  symbol: PEK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: Trp
  symbol: TRP
  source: hgnc_alias_symbol
  hgnc_symbol: TYRP1
  entrez: '7306'
- word: PKI
  symbol: PKI
  source: bioentities_symbol
  hgnc_symbol: PKIB
  entrez: '5570'
- word: PK
  symbol: P(k)
  source: hgnc_alias_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: PKI
  symbol: PKI
  source: bioentities_symbol
  hgnc_symbol: PKIA
  entrez: '5569'
- word: QPRT
  symbol: QPRT
  source: hgnc_symbol
  hgnc_symbol: QPRT
  entrez: '23475'
- word: PKI
  symbol: PKI
  source: bioentities_symbol
  hgnc_symbol: PKIG
  entrez: '11142'
chemicals:
- word: RES
  source: MESH
  identifier: C466160
- word: MDA RES
  source: MESH
  identifier: C466160
- word: Trp
  source: MESH
  identifier: C509690
- word: L-Asp
  source: MESH
  identifier: C108952
- word: Gin Glu
  source: MESH
  identifier: C094686
- word: NAMN
  source: ''
  identifier: ''
- word: Glu
  source: MESH
  identifier: C094686
- word: Glucose
  source: MESH
  identifier: D005947
- word: NAD
  source: MESH
  identifier: D009243
- word: NADS
  source: MESH
  identifier: C055737
- word: NADH
  source: MESH
  identifier: D009243
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Lactate
  source: MESH
  identifier: D019344
- word: NAMPT
  source: MESH
  identifier: C085455
- word: TCA
  source: MESH
  identifier: C000589078
- word: Citrate
  source: MESH
  identifier: C102006
- word: Succinate
  source: MESH
  identifier: D013386
- word: ADP
  source: MESH
  identifier: D000244
- word: ATP
  source: MESH
  identifier: D000255
diseases: []
---
